Chief Business Officer @ Symbal Therapeutics (January 2015 - December 2017)
Strategy and Management Consultant @ (January 2014 - December 2015)
Corporate Strategy and Portfolio Management @ (January 2013 - December 2013)
Senior Clinical Research Specialist; R and D Design Engineer @ (January 2008 - December 2012)
Barry Wohl Education
Harvard Business School
MBA
Stanford University
MS, Mechanical Engineering
Columbia University in the City of New York
BS, Biomedical Engineering
Barry Wohl Skills
Clinical Trials
Life Science Industry
Project Management
Class III Medical Devices
Strategic Planning
Regulatory Affairs
Product Development
Business Strategy
FDA
Life Sciences
Biomedical Engineering
R&D
Healthcare
Leadership
Entrepreneurship
Medical Devices
Pharmaceutical Industry
Clinical Research
Business Planning
U.S. Food and Drug Administration (FDA)
Microsoft Excel
Customer Service
Marketing
Research And Development R&D
U.S. Food And Drug Administration Fda
Research and Development
u.s. Food and Drug Administration
Barry Wohl Summary
Barry Wohl, based in Cambridge, MA, US, is currently a Chief Business Officer at Apnimed. Barry Wohl brings experience from previous roles at Macrolide Pharma (now Zikani Therapeutics), Symbal Therapeutics, IMS Consulting Group and Biogen Idec. Barry Wohl holds a MBA @ Harvard Business School. With a robust skill set that includes Clinical Trials, Life Science Industry, Project Management, Class III Medical Devices, Strategic Planning and more. Barry Wohl has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Barry Wohl?
Find contact details for 700 million professionals.